UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	June 6, 2019

Accession Number:	0001193125-19-052968
Submission Type:	POS AM
CIK: 0001652130 Company Name: Intellia Therapeutics, Inc. File Number: 333-227814